DarioHealth Corp. (DRIO) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$6.48M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$7.31M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$9.48M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$9.20M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$6.48M | (m) | (m) | (m) | $38.00K* | -$6.08M* | $1.99M | $2.10M | (m) | $328.00K |
| 2026-03-31 | Reported | (m) | -$7.31M | (m) | (m) | (m) | $31.00K | -$6.03M | $2.38M | $2.38M | (m) | $57.00K |
| 2025-09-30 | Reported | (m) | -$9.48M | (m) | (m) | (m) | $41.00K* | -$7.35M* | $1.99M | $3.33M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$9.20M | (m) | (m) | (m) | $44.00K* | -$6.03M* | $2.40M | $3.72M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$9.41M | (m) | (m) | (m) | $31.00K | -$6.67M | $2.87M | $4.11M | (m) | $22.00K |
| 2024-09-30 | Reported | (m) | -$12.03M | (m) | (m) | (m) | $32.00K* | -$7.36M* | $3.55M | $5.45M | (m) | -$13.00K |
| 2024-06-30 | Reported | (m) | -$16.19M | (m) | (m) | (m) | $29.00K* | -$11.36M* | $3.50M | $6.81M | (m) | -$1.99M* |
| 2024-03-31 | Reported | (m) | -$17.86M | (m) | (m) | (m) | $56.00K | -$13.11M | $3.33M | $6.64M | (m) | $0.00 |
| 2023-09-30 | Reported | (m) | -$15.55M | (m) | (m) | (m) | $281.00K* | -$8.64M* | $2.91M | $5.67M | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$14.02M | (m) | (m) | (m) | $146.00K* | -$9.64M* | $4.08M | $5.22M | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$12.41M | (m) | (m) | (m) | $74.00K | -$4.76M | $3.90M | $5.17M | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$14.57M | (m) | (m) | (m) | $174.00K* | -$10.70M* | $4.80M | $4.80M | (m) | $0.00* |
| 2022-06-30 | Reported | (m) | -$17.36M | (m) | (m) | (m) | $159.00K* | -$11.12M* | $5.04M | $4.14M | (m) | $1.00K |
| 2022-03-31 | Reported | (m) | -$15.87M | (m) | (m) | (m) | $66.00K | -$18.09M | $4.07M | $5.93M | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$22.50M | (m) | (m) | (m) | $96.00K* | -$12.44M* | $4.80M | $5.51M | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$18.00M | (m) | (m) | (m) | $29.00K* | -$12.31M* | $3.03M | $3.74M | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$14.33M | (m) | (m) | (m) | $68.00K | -$10.53M | $1.99M | $2.65M | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$6.60M | (m) | (m) | (m) | $28.00K* | -$3.79M* | $1.49M | $954.00K | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$4.12M | (m) | (m) | (m) | $13.00K* | -$2.64M* | $1.15M | $825.00K | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$10.11M | (m) | (m) | (m) | $28.00K | -$4.54M | $888.00K | $1.23M | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$2.80M | (m) | (m) | (m) | $8.00K* | -$3.38M* | $995.00K | $859.00K | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$5.36M | (m) | (m) | (m) | $26.00K* | -$5.50M* | $1.32M | $991.00K | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$5.36M | (m) | (m) | (m) | $45.00K | -$3.99M | $1.68M | $1.00M | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$4.05M | (m) | (m) | (m) | $26.00K* | -$3.24M* | $1.41M | $997.00K | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$5.79M | (m) | (m) | (m) | $11.00K* | -$2.03M* | $1.54M | $1.01M | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$2.92M | (m) | (m) | (m) | $12.00K | -$2.77M | $1.20M | $742.00K | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$2.98M | (m) | (m) | (m) | $33.00K* | -$2.40M* | $1.10M | $797.00K | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$4.12M | (m) | (m) | (m) | $31.00K* | -$2.74M* | $850.00K | $1.18M | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$4.21M | (m) | (m) | (m) | $0.00 | -$3.08M | (m) | $469.00K | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$2.72M | (m) | (m) | (m) | $160.00K* | -$2.72M* | (m) | $659.00K | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$2.62M | (m) | (m) | (m) | $211.00K* | -$1.69M* | (m) | $521.00K | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$1.92M | (m) | (m) | (m) | $35.00K | -$2.10M | (m) | $397.00K | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$2.55M | (m) | (m) | (m) | $24.00K* | (m) | (m) | $667.00K | (m) | (m) |
| 2015-06-30 | Reported | (m) | -$1.51M | (m) | (m) | (m) | $10.00K* | (m) | (m) | $441.00K | (m) | (m) |
| 2015-03-31 | Reported | (m) | -$1.78M | (m) | (m) | (m) | $36.00K | (m) | (m) | $883.00K | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$2.51M | (m) | (m) | (m) | $69.00K* | (m) | (m) | $769.00K | (m) | (m) |
| 2014-06-30 | Reported | (m) | -$3.60M | (m) | (m) | (m) | $34.00K* | (m) | (m) | $1.33M | (m) | (m) |
| 2014-03-31 | Reported | (m) | -$2.67M | (m) | (m) | (m) | $116.00K | (m) | (m) | $1.11M | (m) | (m) |
| 2013-09-30 | Reported | (m) | -$3.24M | (m) | (m) | (m) | $162.00K* | -$2.45M* | (m) | $1.08M | (m) | (m) |
| 2013-06-30 | Reported | (m) | -$3.60M | (m) | (m) | (m) | $684.00K* | -$2.05M* | (m) | $1.42M | (m) | (m) |
| 2013-03-31 | Reported | (m) | -$3.08M | (m) | (m) | (m) | $462.00K | -$971.29K | (m) | $675.00K | (m) | (m) |
| 2012-09-30 | Reported | (m) | -$1.02M | (m) | (m) | (m) | $11.56K* | -$723.99K* | (m) | $391.27K | (m) | (m) |
| 2012-06-30 | Reported | (m) | -$866.35K | (m) | (m) | (m) | $12.55K* | -$479.26K* | (m) | $449.15K | (m) | (m) |
| 2012-03-31 | Reported | (m) | -$494.75K | (m) | (m) | (m) | $9.53K | -$316.01K | (m) | $171.67K | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$36.66M | (m) | (m) | (m) | $142.00K | -$25.94M | $9.69M | $13.79M | (m) | $105.00K |
| 2024-12-31 | Reported | (m) | -$57.74M | (m) | (m) | (m) | $138.00K | -$38.56M | $13.77M | $24.18M | (m) | -$1.85M |
| 2023-12-31 | Reported | (m) | -$56.19M | (m) | (m) | (m) | $584.00K | -$30.38M | $14.37M | $20.25M | (m) | $64.00K |
| 2022-12-31 | Reported | (m) | -$56.81M | (m) | (m) | (m) | $442.00K | -$47.84M | $18.00M | $19.65M | (m) | $4.00K |
| 2021-12-31 | Reported | (m) | -$76.49M | (m) | (m) | (m) | $261.00K | -$50.41M | $16.55M | $17.22M | (m) | $32.00K |
| 2020-12-31 | Reported | (m) | -$29.90M | (m) | (m) | (m) | $118.00K | -$17.74M | $5.06M | $4.43M | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$17.70M | (m) | (m) | (m) | $98.00K | -$15.72M | $4.96M | $3.69M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$17.69M | (m) | (m) | (m) | $71.00K | -$11.47M | $5.63M | $3.68M | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$14.42M | (m) | (m) | (m) | $195.00K | -$10.62M | $3.86M | $3.30M | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$11.10M | (m) | (m) | (m) | $808.00K | -$8.38M | (m) | $2.15M | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$7.70M | (m) | (m) | (m) | $110.00K | (m) | (m) | $2.56M | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$11.36M | (m) | (m) | (m) | $563.00K | (m) | (m) | $3.94M | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$13.56M | (m) | (m) | (m) | $1.40M | (m) | (m) | $4.91M | (m) | (m) |
| 2012-12-31 | Reported | (m) | -$3.97M | (m) | (m) | (m) | $534.63K | (m) | (m) | $1.50M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |